Published in Bioorg Med Chem Lett on November 20, 2009
Affinity of aporphines for the human 5-HT2A receptor: insights from homology modeling and molecular docking studies. Bioorg Med Chem (2010) 0.95
Cytotoxicity of aporphines in human colon cancer cell lines HCT-116 and Caco-2: an SAR study. Bioorg Med Chem Lett (2011) 0.88
New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine. Bioorg Med Chem (2011) 0.87
Evaluation of structural effects on 5-HT(2A) receptor antagonism by aporphines: identification of a new aporphine with 5-HT(2A) antagonist activity. Bioorg Med Chem Lett (2014) 0.83
A New Route to Azafluoranthene Natural Products via Direct Arylation. European J Org Chem (2013) 0.79
C4 phenyl aporphines with selective h5-HT(2B) receptor affinity. Bioorg Med Chem Lett (2015) 0.75
Facile total synthesis of lysicamine and the anticancer activities of the Ru(II), Rh(III), Mn(II) and Zn(II) complexes of lysicamine. Oncotarget (2017) 0.75
Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model. Crit Care Med (2005) 1.76
Adolescent ecstasy and other drug use in the National Survey of Parents and Youth: the role of sensation-seeking, parental monitoring and peer's drug use. Addict Behav (2008) 1.44
[3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion]. Rev Neurol (2005) 1.42
3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans. Addiction (1994) 1.22
Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans. Neuropsychopharmacology (2000) 1.19
Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology (Berl) (1999) 1.18
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology (Berl) (2003) 1.17
3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology (Berl) (2002) 1.10
Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice. Psychopharmacology (Berl) (2004) 1.05
Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys. Drug Alcohol Depend (2005) 1.00
The subjective effects of MDMA and mCPP in moderate MDMA users. Drug Alcohol Depend (2001) 0.99
(+/-)-Nantenine analogs as antagonists at human 5-HT(2A) receptors: C1 and flexible congeners. Bioorg Med Chem Lett (2009) 0.97
Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) in rats. Pharmacol Biochem Behav (2007) 0.97
Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists. Br J Pharmacol (2004) 0.96
Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin. Neuropsychopharmacology (2001) 0.95
The psychological and physiological effects of MDMA on normal volunteers. J Psychoactive Drugs (1987) 0.95
Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? Am J Drug Alcohol Abuse (1992) 0.95
High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")-induced Fos expression in a region-specific manner. Neuroscience (2007) 0.95
Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users. Psychopharmacology (Berl) (2005) 0.93
Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis. Life Sci (1990) 0.91
Microwave-Assisted Direct Biaryl Coupling: First Application to the Synthesis of Aporphines. Tetrahedron Lett (2009) 0.89
Structure-activity relationship on (+/-)-nantenine derivatives in antiserotonergic activities in rat aorta. Can J Physiol Pharmacol (2002) 0.88
Structure-activity relationship studies with (+/-)-nantenine derivatives for alpha1-adrenoceptor antagonist activity. Eur J Pharmacol (2002) 0.83
Role of alpha1-adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse. Br J Pharmacol (2007) 0.83
3,4-Methylenedioxymethamphetamine, serotonin and memory. J Pharmacol Exp Ther (1993) 0.82
Intramolecular oxidative coupling of monophenolic benzylisoquinolines. Quinonoid oxoaporphines. J Am Chem Soc (1973) 0.81
Suppressive effect of nantenine, isolated from Nandina domestica Thunberg, on the 5-hydroxy-L-tryptophan plus clorgyline-induced head-twitch response in mice. Life Sci (2002) 0.80
Biological evaluation of compounds for their physical dependence potential and abuse liability. X. Drug testing programs of the Committee on Problems of Drug Dependence, Inc. (1986). NIDA Res Monogr (1987) 0.78
Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS One (2011) 1.69
In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology (2012) 1.61
A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A. Bioorg Med Chem Lett (2004) 1.60
Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal Chem (2011) 1.45
Synthesis of salvinorin A analogues as opioid receptor probes. J Nat Prod (2006) 1.39
Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. Biochem Pharmacol (2012) 1.32
MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl) (2006) 1.26
The value of nonhuman primates in drug abuse research. Exp Clin Psychopharmacol (2007) 1.19
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues. J Med Chem (2007) 1.18
Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys. Neuropsychopharmacology (2009) 1.18
Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds. Forensic Sci Int (2013) 1.16
Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin A in nonhuman primates. Synapse (2005) 1.13
Kappa opioids as potential treatments for stimulant dependence. AAPS J (2005) 1.08
Comments on 'Effect of pioglitazone on testosterone in eugonadal men with type 2 diabetes mellitus: a randomized double-blind placebo controlled study'. Clin Endocrinol (Oxf) (2013) 1.07
Herkinorin analogues with differential beta-arrestin-2 interactions. J Med Chem (2008) 1.03
(+/-)-Nantenine analogs as antagonists at human 5-HT(2A) receptors: C1 and flexible congeners. Bioorg Med Chem Lett (2009) 0.97
Prevalence and severity of vitamin D deficiency in patients with diabetic foot infection. Br J Nutr (2012) 0.96
Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy. J Pharmacol Exp Ther (2013) 0.95
Affinity of aporphines for the human 5-HT2A receptor: insights from homology modeling and molecular docking studies. Bioorg Med Chem (2010) 0.95
Hypoglycemic effects of steroidal sapogenins isolated from Jamaican bitter yam, Dioscorea polygonoides. Food Chem Toxicol (2005) 0.94
Escalation of food-maintained responding and sensitivity to the locomotor stimulant effects of cocaine in mice. Pharmacol Biochem Behav (2009) 0.91
Nantenine as an acetylcholinesterase inhibitor: SAR, enzyme kinetics and molecular modeling investigations. J Enzyme Inhib Med Chem (2010) 0.91
Microwave-Assisted Direct Biaryl Coupling: First Application to the Synthesis of Aporphines. Tetrahedron Lett (2009) 0.89
AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies. Neuropharmacology (2012) 0.89
Cytotoxicity of aporphines in human colon cancer cell lines HCT-116 and Caco-2: an SAR study. Bioorg Med Chem Lett (2011) 0.88
New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine. Bioorg Med Chem (2011) 0.87
Orally active esters of dihydroartemisinin: Synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in mice. Bioorg Med Chem Lett (2008) 0.81
Δ9-THC exposure attenuates aversive effects and reveals appetitive effects of K2/'Spice' constituent JWH-018 in mice. Behav Pharmacol (2014) 0.81
Aporphinoid antagonists of 5-HT2A receptors: further evaluation of ring A substituents and the size of ring C. Chem Biol Drug Des (2014) 0.81
Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse. J Med Chem (2013) 0.79
Conversion of antimalarial drug artemisinin to a new series of tricyclic 1,2,4-trioxanes1. Org Lett (2007) 0.79
A New Route to Azafluoranthene Natural Products via Direct Arylation. European J Org Chem (2013) 0.79
New orally active derivatives of artemisinin with high efficacy against multidrug-resistant malaria in mice. J Med Chem (2006) 0.79
Synthesis of C-Homoaporphines via Microwave-Assisted Direct Arylation. Tetrahedron (2011) 0.79
Targeted metabolomic approach for assessing human synthetic cannabinoid exposure and pharmacology. Anal Chem (2013) 0.78
Quantitative measurement of acetyl fentanyl and acetyl norfentanyl in human urine by LC-MS/MS. Anal Chem (2014) 0.78
Streamlined catalytic asymmetric synthesis of atorvastatin. Chemistry (2013) 0.76
Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine. Drug Alcohol Depend (2011) 0.76
Predisposing effects of neonatal visceral pain on abuse-related effects of morphine in adult male Sprague Dawley rats. Psychopharmacology (Berl) (2014) 0.76
Novel technology for modulating locomotor activity as an operant response in the mouse: implications for neuroscience studies involving "exercise" in rodents. J Neurosci Methods (2012) 0.76
Linker-based hemisuccinate derivatives of artemisinin: synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice. J Med Chem (2012) 0.75
Leonurenones A-C: Labdane diterpenes from Leonotis leonurus. Phytochemistry (2012) 0.75
New Drimane Sesquiterpenoids from Tidestromia oblongifolia. Nat Prod Commun (2008) 0.75
Enantioselective synthesis of (2R,3R)- and (2S,3S)-2- [(3-chlorophenyl)-(2-methoxyphenoxy)methyl]morpholine. Tetrahedron Asymmetry (2005) 0.75
Non-ribosomal peptide synthetases: Identifying the cryptic gene clusters and decoding the natural product. J Biosci (2017) 0.75
High-Affinity Nucleic-Acid Based Receptors for Steroids. ACS Chem Biol (2017) 0.75